Are Options Traders Bullish on AUPH?
Let daily Option Order Flow show you where stock investors are Bullish and Bearish!!! Receive a FREE daily email of the Market Chameleon Order Flow Sentiment Newsletter.
Market Chameleon

Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

About AUPH

Aurinia is a clinical stage pharmaceutical company focused on the global nephrology market. It is currently in the recruitment and enrollment phase of its Phase 2b clinical trial to evaluate the efficacy of its drug, voclosporin, as a treatment for lupus nephritis (LN). LN is an inflammation of the kidneys, that if inadequately treated can lead to end-stage renal disease, making LN a serious and potentially life-threatening condition.
Primary Exchange: NASDAQ
SIC
NAICS Pharmaceutical Preparation Manufacturing

AUPH is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
BIB ProShares Ultra Nasdaq Biotechnology 303.7 M 3.03719E+08 202 202 0.03% 0.000275923 176 K 176439
IBB iShares Nasdaq Biotechnology Index Fund 8.1 B 8.09038E+09 191 191 0.06% 0.0006 5.1 M 5148210
UBIO Proshares UltraPro Nasdaq Biotechnology 30.0 M 2.99783E+07 196 196 0.01% 0.000126441 13 K 12787

Wait, Before You Leave...